Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-042313
Filing Date
2014-06-18
Accepted
2014-06-18 16:16:08
Documents
1
Period of Report
2014-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15198
  Complete submission text file 0001209191-14-042313.txt   16398
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MUELLER PETER (Reporting) CIK: 0001256126 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 14928244